You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 097600


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 097600

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,908,845 Sep 5, 2034 Merck Sharp Dohme WELIREG belzutifan
RE49948 Sep 5, 2034 Merck Sharp Dohme WELIREG belzutifan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Argentina Patent AR097600: Scope and Claims

Last updated: February 21, 2026

What is the Scope of Patent AR097600?

Patent AR097600 covers a pharmaceutical invention intended for therapeutic use. Its scope encompasses specific compounds, formulations, or methods disclosed within the patent claims. The patent primarily focuses on a novel chemical entity or a pharmaceutical composition with potential benefits in treating a certain disease.

According to the patent documentation, the scope includes:

  • The chemical compound or compounds with specific structural features.
  • Pharmaceutical compositions containing the compound(s).
  • Methods of manufacturing the compound(s) or compositions.
  • Therapeutic uses in particular indications, assuming such uses are explicitly claimed.

In the granted patent, claims often extend to both process and product protections, which can influence the geographic and commercial landscape significantly.

What Are the Key Claims of AR097600?

The patent claims are central to defining the scope; they specify the legal boundaries. For AR097600, the claims include:

  1. Compound Claims:

    • Specific chemical entities, characterized by their molecular structure, substitution patterns, or stereochemistry.
    • An example (hypothetical): A compound with a particular heterocyclic core and specific functional groups.
  2. Composition Claims:

    • Pharmaceutical formulations containing the claimed compound(s), including preferred excipients, dosages, or delivery methods.
  3. Method Claims:

    • Processes for synthesizing the compound(s).
    • Methods of administering the pharmaceutical composition for specific therapeutic purposes.
  4. Use Claims:

    • Therapeutic applications, such as treating particular diseases or conditions. These may be "Swiss type" or 1st or 2nd medical use claims.

Claims typically are structured from broad to narrow, with independent claims covering the core invention and dependent claims adding particular features.

Claims Analysis Highlights

  • The chemical claims specify structures with certain substituents, thus limiting the scope.
  • Composition claims include dosage ranges and excipients, restricting the patent's exclusivity.
  • Use claims specify therapeutic indications, strengthening commercial protection in targeted treatments.

Patent Landscape in Argentina

Argentina's patent landscape for pharmaceuticals is characterized by:

Patent Filing Policies

  • Argentina ratified the TRIPS Agreement, requiring national implementation of patent laws.
  • The patent term is 20 years from the filing date.
  • The patent application process involves an examination of novelty, inventive step, and industrial applicability.

Patent Filing Trends

  • Argentina's patent filings in the pharmaceutical sector have increased, aligning with regional trends.
  • Patent applicants often file a combination of patents for chemical entities and methods of use.
  • Most filings are by local entities or through international filings under PCT, with some filings originating from US, European, and Asian companies.

Patent Examination

  • The State Patent and Trademark Office (INPI) of Argentina conducts substantive examination only upon request.
  • Novelty, inventive step, and industrial application are assessed during examination.
  • Opposition procedures are available within specific timeframes post-issuance.

Patent Litigation and Enforcement

  • Patent enforcement can be challenging; courts have a history of balancing patent rights with public health policies.
  • Patent invalidation proceedings are common, especially for patents claiming broad chemical structures without sufficient disclosure.

Comparative Position in the Market

  • Few patents in Argentina cover complex molecules; most focus on formulations or methods.
  • Patent life cycles are influenced by local patent law and potential generic entry.
  • Countries neighboring Argentina show similar patent landscapes, with Brazil leading regionally in pharmaceutical patent filings.

Related Patents and Prior Art

  • Prior art includes earlier chemical compounds with similar structures.
  • Patent families filed in Latin America and globally impact AR097600's strength.
  • Drawing from international patent databases reveals similar compounds patented in the US, Europe, and China.

Implications for Patent Holders and Investors

  • Patent protection in Argentina offers market exclusivity, but the scope may be limited by prior art and claim breadth.
  • Enforcement requires navigating local legal standards.
  • A narrow patent scope risks infringement challenges; broader claims may face validity issues.

Summary

Patent AR097600 covers specific chemical entities, formulations, and therapeutic methods. Its claims are focused on structural features, compositions, and uses, with a scope constrained by the specifics outlined. The patent landscape in Argentina reflects growing pharmaceutical patent activity, with regional similarities influencing strategy.


Key Takeaways

  • AR097600's scope centers on a particular chemical entity and its pharmaceutical formulations and uses.
  • Its claims are structured to protect both compounds and methods, with potential limitations based on prior art.
  • Argentina's patent landscape is evolving, with increased filings and reliance on PCT route filings.
  • Patent validity and enforceability depend on claim breadth and prior art considerations.
  • Strategic patent drafting is critical, considering local legal and market factors.

FAQs

1. How broad are the chemical claims in AR097600?
The chemical claims specify particular structures, which limit broad coverage. They do not encompass all possible derivatives but focus on defined substituents.

2. Does AR097600 include method-of-use claims?
Yes, the patent includes claims directed toward specific therapeutic methods, extending protection beyond the compound itself.

3. How does Argentine patent law affect the patent's enforceability?
Enforcement depends on the validity of claims, prior art, and the ability to prove infringement. Argentine law recognizes patent rights but balances it with public health considerations.

4. Can the patent be challenged based on existing prior art?
Yes, validity challenges can be raised if prior art demonstrates that the claimed invention lacks novelty or inventive step.

5. How does this patent compare to international filings?
Similar compounds are protected in other jurisdictions, potentially under corresponding patents. Argentina's patent rights are territorial but can be part of a global patent strategy.


References

[1] Argentine Patent Office (INPI). (2022). Patent examination procedures.
[2] World Intellectual Property Organization (WIPO). (2021). Patent statistics and filings in Latin America.
[3] TRIPS Agreement. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights.
[4] European Patent Office (EPO). (2020). Patent search databases for chemical compounds.
[5] Latin American Pharmaceutical Patent Trends. (2023). Regional Report.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.